Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 60.00% vs 117.11% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 28.60% vs -119.09% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -11.22% vs 7.20% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -23.14% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of ImmunityBio, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 60.00% vs 117.11% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,540.00% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 28.60% vs -119.09% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 31.20% vs 2.60% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -11.22% vs 7.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 28.98% vs -20.43% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -23.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -25.90% vs 20.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






